0 CHECKOUT

PRODUCT FILTERS

REGION

4
1
1
1

COUNTRY

1

CATEGORIES

  • 8
  • 8
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

4
10
16
28

PUBLISHED

0
4
7
28

PRODUCT TYPE

18
7
2
1

Search for: "BioMimetic Therapeutics Inc-Therapeutic Competitors"

28 Products

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update

Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics,...

Published:  May 2014
Price:  From

BioMimetic Therapeutics, Inc. - Strategic SWOT Analysis Review

BioMimetic Therapeutics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

Published:  February 2014
Price:  From

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update

Summary BioMimetic Therapeutics, Inc. (BioMimetic), subsidiary of Wright Medical Group, Inc., is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal...

Published:  June 2013
Price:  From

BioMimetic Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

Published:  June 2013
Price:  From

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human platelet-derived...

Published:  April 2012
Price:  From

BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review

BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human...

Published:  September 2011
Price:  From

Rhinovirus Infection - Pipeline Review, H2 2014

Rhinovirus Infection - Pipeline Review, H2 2014 Summary This, ‘Rhinovirus Infection - Pipeline Review, H2 2014’, provides an overview of the Rhinovirus Infection’s therapeutic pipeline. This report...

Published:  December 2014
Price:  From

Pancreatic Cancer - Pipeline Review, H1 2015

Pancreatic Cancer - Pipeline Review, H1 2015 Summary the, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Prostate Cancer - Pipeline Review, H1 2015

Prostate Cancer - Pipeline Review, H1 2015 Summary the, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

Published:  May 2014
Price:  From

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

Published:  February 2014
Price:  From

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Inflammation - Pipeline Review, H1 2014’, provides an overview of the Inflammation’s therapeutic pipeline. This report provides...

Published:  June 2014
Price:  From

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014 Summary This, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014’, provides...

Published:  October 2014
Price:  From

Sickle Cell Disease - Pipeline Review, H1 2014

Sickle Cell Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2014’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This...

Published:  April 2014
Price:  From

Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014

Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014 Summary This, ‘Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014’, provides an overview of the Pseudomonas Aeruginosa Infections’s...

Published:  November 2014
Price:  From

Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015

Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015 Summary This, ‘Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015’, provides an overview of the Pseudomonas Aeruginosa Infections’s...

Published:  June 2015
Price:  From

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015 Summary the, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides...

Published:  June 2015
Price:  From

Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Dry Eye Syndrome Therapeutics -...

Published:  March 2011
Price:  From

Regenerative Medicine - Global Strategic Business Report

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World....

Published:  June 2014
Price:  From

Growth Factors (Blood and Tissue) - Global Strategic Business Report

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons,...

Published:  June 2014
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.